Sector
PharmaceuticalsOpen
₹330Prev. Close
₹327Turnover(Lac.)
₹6.38Day's High
₹330Day's Low
₹32952 Week's High
₹47752 Week's Low
₹112.5Book Value
₹72.03Face Value
₹10Mkt Cap (₹ Cr.)
320.45P/E
0EPS
0Divi. Yield
016 Dec 2024
12:00 AM
EGM
16 Sep 2024
12:00 AM
AGM
Announcement Date: 16 Sep, 2024
21 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 37.84 | 38.21 | 38.8 | 38.58 |
Net Worth | 45.84 | 46.21 | 46.8 | 46.58 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 181.56 | 167.21 | 112.17 | 106.89 |
yoy growth (%) | 8.58 | 49.06 | 4.93 | 7.45 |
Raw materials | -107.76 | -96.48 | -69.68 | -67.53 |
As % of sales | 59.35 | 57.7 | 62.12 | 63.18 |
Employee costs | -15.26 | -13.3 | -9.34 | -8.73 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 17.27 | 14.09 | 2.36 | 1.78 |
Depreciation | -3.37 | -3.2 | -2.67 | -2.44 |
Tax paid | -3.55 | -3.19 | -0.65 | -0.43 |
Working capital | 10.52 | 12.18 | 7.8 | -5.96 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 8.58 | 49.06 | 4.93 | 7.45 |
Op profit growth | 19.19 | 170.64 | 17.86 | 0.43 |
EBIT growth | 17.93 | 240.9 | 12.5 | 25.41 |
Net profit growth | 25.86 | 535.77 | 26.77 | 649.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672.5 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,833.1 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485.05 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,313.15 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
S K Hari Krishna
Non Executive Director
Raju S Kakarlapudi
Company Sec. & Compli. Officer
Abdur Rahman
Independent Director
SUNDARA PRASAD VENKATA SATYA SRIKAKOLAPU
Independent Director
Venkata Satyanarayana Murthy Vadali
Aroor Village,
Sadasivpet Mandal,
Telangana - 502291
Tel: 91-8455-250113
Website: http://www.everestorganicsltd.com
Email: eolcs0405@gmail.com
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Everest Organics Limited was incorporated at Hyderabad in February, 1993. It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju. The Company is engaged in manufacturing of Active Pharmace...
Read More
Reports by Everest Organics Ltd
What is the Everest Organics Ltd share price today?
What is the Market Cap of Everest Organics Ltd?
What is the PE and PB ratio of Everest Organics Ltd?
What is the 52 Week High and Low of Everest Organics Ltd?
What is the CAGR of Everest Organics Ltd?
What is the shareholding pattern of Everest Organics Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.